Food Bioscience, Journal Year: 2024, Volume and Issue: unknown, P. 105822 - 105822
Published: Dec. 1, 2024
Language: Английский
Food Bioscience, Journal Year: 2024, Volume and Issue: unknown, P. 105822 - 105822
Published: Dec. 1, 2024
Language: Английский
Food Bioscience, Journal Year: 2025, Volume and Issue: unknown, P. 105925 - 105925
Published: Jan. 1, 2025
Language: Английский
Citations
1Journal of Cellular and Molecular Medicine, Journal Year: 2025, Volume and Issue: 29(2)
Published: Jan. 1, 2025
ABSTRACT The clinical application of doxorubicin (DOX) is limited due to its cardiotoxicity, which primarily attributed interaction with iron in mitochondria, leading lipid peroxidation and myocardial ferroptosis. This study aimed investigate the role gut microbiota‐derived metabolite, indole‐3‐lactic acid (ILA), mitigating DOX‐induced cardiotoxicity (DIC). Cardiac function, pathological changes, ferroptosis were assessed vivo. cardioprotective effects mechanisms ILA explored using multi‐omics approaches, including single‐nucleus RNA sequencing (snRNA‐seq) bulk RNA‐seq, further validated Nrf2 knockout mice. findings revealed that DOX treatment disrupted microbiota, significantly reducing levels tryptophan metabolite ILA. In DIC models, supplementation markedly improved cardiac reduced collagen deposition, mitigated atrophy. snRNA‐seq analyses indicated played a crucial Experimental data demonstrated decreased both mice DOX‐treated H9C2 cells, evidenced by restoration GPX4 SLC7A11 reduction ACSL4. Mechanistically, functions as ligand for aryl hydrocarbon receptor (AhR), upregulation expression. protective against abolished silencing AhR. Moreover, beneficial on eliminated Nrf2‐deficient conclusion, exerts therapeutic inhibiting through activation AhR/Nrf2 signalling pathway. Identifying microbial could offer viable strategies DIC.
Language: Английский
Citations
1Gut Microbes Reports, Journal Year: 2025, Volume and Issue: 2(1)
Published: April 10, 2025
Language: Английский
Citations
1Food Bioscience, Journal Year: 2025, Volume and Issue: unknown, P. 106158 - 106158
Published: Feb. 1, 2025
Language: Английский
Citations
0Life Sciences, Journal Year: 2025, Volume and Issue: unknown, P. 123557 - 123557
Published: March 1, 2025
Language: Английский
Citations
0ACS Infectious Diseases, Journal Year: 2025, Volume and Issue: unknown
Published: May 15, 2025
The interplay between probiotic metabolites, host health, and inhibition of pathogens has increasingly attracted interest but remains unresolved due to the complex molecular interactions among these factors. We investigated action cell-free supernatants (CFSs) from two bacteria, Bifidobacterium animalis spp. lactis (B. lactis) HN019 Lacticaseibacillus rhamnosus (L. rhamnosus) HN001 their effect against bacterial pathogen Shigella flexneri 2457T (S. flexneri). CFSs B. exhibited a higher antibacterial S. growth than L. HN001, independent carbon source utilized. This correlated with formate within HN019. As expected, antimicrobial effects were stronger free cells for infecting cells. A synergistic additional small organic molecules such as indole-3-lactate was found. Such CFSs, indole-3-lactate, reflected by altered metabolic rates in presence both solution under biofilm-forming conditions. different components acting on gives reasons believe that suitably designed mixtures products small-molecule effectors bear promise successfully combating pathogens.
Language: Английский
Citations
0Chinese Medicine, Journal Year: 2024, Volume and Issue: 19(1)
Published: Sept. 15, 2024
Language: Английский
Citations
3LWT, Journal Year: 2024, Volume and Issue: 215, P. 117216 - 117216
Published: Dec. 14, 2024
Language: Английский
Citations
0Food Bioscience, Journal Year: 2024, Volume and Issue: unknown, P. 105822 - 105822
Published: Dec. 1, 2024
Language: Английский
Citations
0